Schizophrenia Research Forum - A Catalyst for Creative Thinking
Home Profile Membership/Get Newsletter Log In Contact Us
 For Patients & Families
What's New
Recent Updates
SRF Papers
Current Papers
Search All Papers
Search Comments
News
Research News
Conference News
Plain English
Forums
Current Hypotheses
Idea Lab
Online Discussions
Virtual Conferences
Interviews
Resources
What We Know
SchizophreniaGene
Animal Models
Drugs in Trials
Research Tools
Grants
Jobs
Conferences
Journals
Community Calendar
General Information
Community
Member Directory
Researcher Profiles
Institutes and Labs
About the Site
Mission
History
SRF Team
Advisory Board
Support Us
How to Cite
Fan (E)Mail
The Schizophrenia Research Forum web site is sponsored by the Brain and Behavior Research Foundation and was created with funding from the U.S. National Institute of Mental Health.
Research News
back to News Search
News Brief: Normal Dopamine Synthesis Capacity in Treatment-Resistant Schizophrenia

Treatment-resistant schizophrenia patients have a lower dopamine synthesis capacity than individuals who respond to antipsychotics, according to a new study published online October 3 in the American Journal of Psychiatry and led by Arsime Demjaha of King’s College London. The dopamine synthesis capacity of treatment-refractive subjects was comparable to that of healthy subjects, suggesting that dopamine-blocking antipsychotic drugs are only effective in those patients who have an elevated dopamine synthesis capacity.

Several studies have reported increased striatal dopamine synthesis capacity in schizophrenia using positron emission tomography (PET) (see SRF related news story). Unfortunately, approximately one third of schizophrenia patients show a limited response to antipsychotic treatment (Lindenmayer, 2000), but just how the hyperdopaminergic state relates to the response to antipsychotics remains unclear.

In the current study, Demjaha and colleagues examined striatal dopamine synthesis capacity in 12 treatment-resistant and 12 treatment-responsive schizophrenia subjects, as well as in 12 healthy controls. They found that dopamine synthesis capacity was elevated in the treatment-responsive subjects, but not in the treatment-resistant subjects or in healthy controls. The elevation was most prominent in the associative and limbic striatal subdivisions.

This finding may explain why symptoms in some patients are not improved with antipsychotics. According to the authors, their data suggest that “patients with treatment-resistant illness start with a different underlying pathophysiology or that antipsychotics have an effect on their dopamine synthesis capacity, albeit one that does not reduce symptoms.” Importantly, since all subjects in the current study were medicated, future studies will need to examine antipsychotic-naïve subjects.—Allison A. Curley.

Reference:
Demjaha A, Murray RM, McGuire PK, Kapur S, Howes OD. Dopamine Synthesis Capacity in Patients With Treatment-Resistant Schizophrenia. Am J Psychiatry. 2012 Oct 3. Abstract

 
Comments on News and Primary Papers
Primary Papers: Dopamine Synthesis Capacity in Patients With Treatment-Resistant Schizophrenia.

Comment by:  Jeffrey Lieberman, SRF Advisor
Submitted 9 October 2012 Posted 9 October 2012
  I recommend this paper

This interesting result is consistent with prior work by...  Read more


View all comments by Jeffrey Lieberman
Submit a Comment on this News Article
Make a comment on this news article. 

If you already are a member, please login.
Not sure if you are a member? Search our member database.

*First Name  
*Last Name  
Affiliation  
Country or Territory  
*Login Email Address  
*Confirm Email Address  
*Password  
*Confirm Password  
Remember my Login and Password?  
Get SRF newsletter with recent commentary?  
 
Enter the code as it is shown below:
This code helps prevent automated registrations.

I recommend the Primary Papers

Please note: A member needs to be both registered and logged in to submit a comment.

Comment:

(If coauthors exist for this comment, please enter their names and email addresses at the end of the comment.)

References:


SRF News
SRF Comments
Text Size
Reset Text Size
Share/Bookmark
Copyright © 2005- 2014 Schizophrenia Research Forum Privacy Policy Disclaimer Disclosure Copyright